Heterogeneous loss-of-function mutations of the human RSK2 gene (RPS6KA3) have been implicated in Coffin–Lowry syndrome, which is characterized by multiple symptoms including growth retardation and cognitive impairment (8). The gene discussed is RPS6KA3; the disease is Cognitive impairment.